Study reveals how p53 mutations cause tumors to resist cancer immunotherapy Post author:admin Post published:July 22, 2026 Post category:uncategorized Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. You Might Also Like Does Cinnamon Really Help People with Diabetes? I Checked the Science January 29, 2024 GP nurses could deliver effective sleep treatments April 22, 2026 Decoding how the brain understands sentences in real-time October 29, 2023